Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy
Article in Scientific Reports (April 2024)
The most recent citing publications are shown below. View all 239 publications that cite this research output on Dimensions.
Article in Scientific Reports (April 2024)
Article in Critical Reviews in Oncology/Hematology (April 2024)
Article (April 2024)